<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03093337</url>
  </required_header>
  <id_info>
    <org_study_id>07 227 01</org_study_id>
    <nct_id>NCT03093337</nct_id>
  </id_info>
  <brief_title>Psychomotor Therapy for Very Premature Infants</brief_title>
  <acronym>VPI</acronym>
  <official_title>Early Post Hospital Discharge Psychomotor Therapy Intervention Program: Effect on the Development in Very Preterm Infants at 2-years Corrected Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our current reflexion is that sensory dys-stimulations, including vestibule-proprioceptive
      disorders and unbalanced between brain and brainstem maturation of the neonatal period
      involve an early deviant development for immature infants that will be cascaded through the
      brain scaffolding and later development. The primary purpose is to determine whether the
      Early Psychomotor Therapy Intervention Program improves development and behavior in very
      preterm infants (VPI) at 24-month corrected age (CA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      VPI &lt; 30 week of amenorrhea were randomized, in a simple blind controlled trial. The
      psychomotor development was evaluated according to the Bayley Scales of Infant
      Development-III (BSID-III) at 2 years CA. An intermediate point was provided at 9 months CA.
      Pediatric standardized assessments and psychologist semi-directive interviews were conducted.
      Parents also completed a self-administering questionnaire relating to the post-traumatic
      stress. The intervention consisted on 20 therapy sessions between 2 and 9 months CA, in order
      to support infants' development, and parent-infant interactions and adjustment.

      Extended description of the protocol, including more technical information (as compared to
      the Brief Summary) if desired. Do not include the entire protocol; do not duplicate
      information recorded in other data elements, such as eligibility criteria or outcome
      measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2007</start_date>
  <completion_date type="Actual">July 8, 2017</completion_date>
  <primary_completion_date type="Actual">December 1, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psychomotor development assessment.</measure>
    <time_frame>Year 2</time_frame>
    <description>Assessed by the Bayley Scale Third Edition BSID-III.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The acceptability of the protocol by the parents for the intervention group.</measure>
    <time_frame>Month 9</time_frame>
    <description>Assessed by a self-questionnaire given by the neonatologist at the end of the treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of parenting.</measure>
    <time_frame>Month 9; Year 2</time_frame>
    <description>Assessed by a grid (established by the team of child psychiatry neonatology).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The clinical evolution of the child assessed by a standardized neurological examination.</measure>
    <time_frame>Months 3, 6, 9, 12, 18, 24</time_frame>
    <description>Assessed during the consultations planned in the network (neonatologists of the CHU), based on a standardized neurological examination.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">162</enrollment>
  <condition>Premature Infant</condition>
  <arm_group>
    <arm_group_label>Psychomotor therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early post hospital discharge psychomotor therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No specific support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early post hospital discharge psychomotor therapy</intervention_name>
    <description>The intervention consisted on 20 psychomotor therapy sessions between 2 and 9 months, in order to support infants' development, and parent-infant interactions and adjustment. The therapy was based on body and emotional positive feelings and experiences, leading to improve sensory motor and perceptive integration, interactive and exploratory behaviors, physiological and tonic-emotional self-regulation, motor organization and early coordination. The intervention was a partnership with the parents, leading to decode the baby needs and expectations, for the parents to experiment more positive feelings, to become more confident in their own skills and more sensitive, and in synchrony with their baby. Intervention was supported by a detailed assessment scale implemented in the regional network related to the follow-up for vulnerable babies.</description>
    <arm_group_label>Psychomotor therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants with a gestational age between 24 and 30 weeks.

        Exclusion Criteria:

          -  Infants with congenital disease,

          -  Infants with brain bleeding grade III-IV,

          -  Infants with periventricular leucomalacia,

          -  Infants whose mothers had a documented history of physical or mental illness, or drug
             abuse

          -  Infants from non-French -speaking families.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>30 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corinne Alberge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital des enfants, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH Albi</name>
      <address>
        <city>Albi</city>
        <state>Midi-Pyrénées</state>
        <zip>81013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Auch</name>
      <address>
        <city>Auch</city>
        <state>Midi-Pyrénées</state>
        <zip>32008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Cahors</name>
      <address>
        <city>Cahors</city>
        <state>Midi-Pyrénées</state>
        <zip>46005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Castres</name>
      <address>
        <city>Castres</city>
        <state>Midi-Pyrénées</state>
        <zip>81108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHIVA centre hospitalier du val d'Ariège</name>
      <address>
        <city>Foix</city>
        <state>Midi-Pyrénées</state>
        <zip>09017</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Montauban</name>
      <address>
        <city>Montauban</city>
        <state>Midi-Pyrénées</state>
        <zip>82013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Tarbes</name>
      <address>
        <city>Tarbes</city>
        <state>Midi-Pyrénées</state>
        <zip>65013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>30159</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sarrus Teinturiers</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Ambroise Paré</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31082</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Shevell MI, Bodensteiner JB. Cerebral palsy: defining the problem. Semin Pediatr Neurol. 2004 Mar;11(1):2-4. Review.</citation>
    <PMID>15132247</PMID>
  </reference>
  <reference>
    <citation>Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediatr. 2001 Mar;90(3):271-7.</citation>
    <PMID>11332166</PMID>
  </reference>
  <reference>
    <citation>Nelson KB. Can we prevent cerebral palsy? N Engl J Med. 2003 Oct 30;349(18):1765-9.</citation>
    <PMID>14585946</PMID>
  </reference>
  <reference>
    <citation>Jacobsson B, Hagberg G. Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol. 2004 Jun;18(3):425-36. Review.</citation>
    <PMID>15183137</PMID>
  </reference>
  <reference>
    <citation>Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997 Apr;39(4):214-23.</citation>
    <PMID>9183258</PMID>
  </reference>
  <reference>
    <citation>Weisglas-Kuperus N, Koot HM, Baerts W, Fetter WP, Sauer PJ. Behaviour problems of very low-birthweight children. Dev Med Child Neurol. 1993 May;35(5):406-16. Review.</citation>
    <PMID>7684346</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>November 5, 2017</last_update_submitted>
  <last_update_submitted_qc>November 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromotor sequelae</keyword>
  <keyword>Cognitive disorders</keyword>
  <keyword>Cerebral development</keyword>
  <keyword>Psychomotoricity</keyword>
  <keyword>Postural management</keyword>
  <keyword>Motor coordination</keyword>
  <keyword>Parenthood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

